Michał Rafał Stojko

Mr. Michał Rafał Stojko


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
KNKamil Nikel
Kamil Nikel
MSMichał Rafał Stojko
Michał Rafał Stojko
JSJoanna Smolarczyk
Joanna Smolarczyk
MPMagdalena Piegza
Magdalena Piegza
The gut microbiota plays a key role in mental health, with growing evidence linking its composition to anxiety and depressive disorders. Research on this topic has expanded significantly in recent years. This review explores alterations in the gut microbiota of individuals with anxiety disorders and examines the potential therapeutic effects of probiotics. Background/Objectives: This review aims to analyze the alterations in gut microbiota composition in individuals with anxiety disorders and evaluate the potential therapeutic effects of probiotics in mitigating symptoms. By examining recent research, this study seeks to highlight the gut–brain connection and its implications for mental health interventions. Materials and Methods: A literature search was conducted in PubMed, Embase, CINAHL, and Google Scholar, focusing on studies investigating the relationship between gut microbiota and anxiety disorders, as well as the impact of probiotics on symptom severity. Results: The reviewed studies suggest that individuals with anxiety disorders often exhibit gut microbiota alterations, including reduced microbial diversity and a lower abundance of short-chain fatty acid-producing bacteria. Additionally, probiotics, particularly those from the Lactobacillus genus, may help alleviate anxiety symptoms by modulating gut microbiota composition. Conclusions: Gut dysbiosis appears to be closely linked to anxiety disorders, and probiotic interventions could represent a promising therapeutic avenue. However, further research is needed to clarify underlying mechanisms and optimize treatment strategies.

8 August 2023 in Medicina
Verified
Journal Article
Open access
PDF file
MSMichał Rafał Stojko
Michał Rafał Stojko
JNJakub Nocoń
Jakub Nocoń
PPPatrycja Piłat
Patrycja Piłat
GSGabriela Szpila
Gabriela Szpila
JSJoanna Smolarczyk
Joanna Smolarczyk
MHMichał Hawranek
Michał Hawranek
Anabolic-androgenic steroids (anabolic-androgenic steroids, AAS) are testosterone-derived compounds whose popularity and use are constantly growing. Chronic use of AAS leads to many hormonal and metabolic disorders in the human body, which often lead to permanent health damage. Changes affect the following systems: cardiovascular, musculoskeletal, reproductive, digestive, and nervous. We decided to collect the existing knowledge in the literature and enrich it with the latest research reports in the field of degenerative effects of AAS on the nervous system. The work aimed to increase public awareness of the dangers and consequences of AAS use and improve it with the latest research on the neurodegenerative effects of AAS. We hope that our work will contribute to raising public awareness and reducing the use of AAS.

28 July 2023 in Medicina
Verified
Journal Article
Open access
PDF file
PPPatrycja Piłat
Patrycja Piłat
GSGabriela Szpila
Gabriela Szpila
MSMichał Rafał Stojko
Michał Rafał Stojko
JNJakub Nocoń
Jakub Nocoń
JSJoanna Smolarczyk
Joanna Smolarczyk
MHMichał Hawranek
Michał Hawranek
Adipocytes accumulate triacylglycerols as an energy store, thereby causing an increase in the adipose tissue volume. Weight gain can be prevented through damage to the adipocyte structure or an increase in the body’s metabolic rate. Commonly used methods to disintegrate the cell membrane of adipocytes include injection lipolysis, cryolipolysis, ultrasonic lipolysis, radiofrequency lipolysis, laser lipolysis, carboxytherapy, and lipolysis using an electromagnetic field. The names of these methods suggest which substances are being used, and their main advantages are a very low invasiveness, as well as effectiveness. However, new discoveries in medicine, along with individuals’ desire to improve their appearance, have resulted in numerous studies on more ways of reducing body fat. Great potential is seen in beige adipocytes, which can be transformed, i.e., “recruited” from white adipocytes, or synthesized de novo; they also show thermogenic properties. One of the stimuli inducing the formation of beige adipocytes is cold and B3-adrenergic stimulation. Based on these findings, the researchers created, for example, cooling clothing. Additionally, curcumin and natural anthocyanins have proven to be helpful in the treatment of obesity and diabetes, by stimulating the secretion of glucagon-like peptide-1, and inducing the formation of beige adipocytes. Another study showed that the conversion of white adipose tissue is indirectly influenced by interleukin-6 secreted by the muscles, the expression of which is increased in people actively exercising. Moreover, there is potential in adenosine analogs, fenoldopam, rhubarb, the herbal extract Ephedra sinica Stapf, electroacupuncture simulation, and the drug CBL-514. Despite knowledge and experience, the ideal method for a quick and noticeable, but safe and non-invasive reduction of body fat has not been found yet. The research conducted nowadays may bring us closer to the development of a universal method, and turn out to be a breakthrough in the fight against overweight and obesity.

27 September 2024 in Viruses
Verified
Journal Article
Open access
PDF file
KŻKarol Jerzy Żmudka
Karol Jerzy Żmudka
JJJerzy Jaroszewicz
Jerzy Jaroszewicz
Dorota Zarębska-MichalukDorota Zarębska-Michaluk
Dorota Zarębska-Michaluk
MRMagdalena Rogalska
Magdalena Rogalska
PCPiotr Czupryna
Piotr Czupryna
Robert FlisiakRobert Flisiak
Robert Flisiak
(1) Background: Liver damage is an important component of acute COVID-19, and the advancement of preexisting liver disease is associated with a worse prognosis; (2) Methods: A nationwide retrospective study including 7444 patients aimed to evaluate levels of selected markers of liver damage and disease advancement and their association with mortality and mechanical ventilation (MV); (3) Results: Elevation of the following markers in multivariate models were associated with increased odds of mortality: Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT), lactate dehydrogenase (LDH), fibrosis-4 score (FIB-4), AST-to-platelet ratio index (APRI), and decreased levels of platelet count (PLT). Elevated levels of AST, LDH, APRI, FIB-4, and the AST/ALT ratio and decreased levels of PLT were associated with increased odds of MV in multivariate models. The best predictive accuracy against mortality was achieved with FIB-4 with AUC = 0.733 (95% CI, 0.718–0.749) at the optimal cut-off point of 2.764, while against MV was achieved with LDH with AUC = 0.753 (95% CI, 0.727–0.778) at the optimal cut-off point of 449.5 IU/L. (4) Conclusions: Our study confirms that the advancement of liver damage contributes to a worse prognosis in COVID-19 patients. Markers for liver damage and the advancement of liver disease can provide predictive value in clinical practice among COVID-19 patients.

31 October 2024 in Life
Verified
Journal Article
Open access
PDF file
MSMichał Rafał Stojko
Michał Rafał Stojko
ASAleksandra Spychał
Aleksandra Spychał
KNKamil Nikel
Kamil Nikel
RKRafał Kołodziej
Rafał Kołodziej
JZJolanta Zalejska-Fiolka
Jolanta Zalejska-Fiolka
Background: Lipoprotein(a) [Lp(a)] is recognized as an independent risk factor for cardiovascular diseases; however, the impact of fat-based diets on its levels remains unclear. Objective: This study aims to assess and analyze current evidence on the impact of various types of fat-based diets on Lp(a) levels. Material and Methods: A comprehensive search of the PubMed database was conducted on 9 July 2024, focusing on clinical and randomized trials published since 2000. Out of 697 identified studies, 33 met the inclusion criteria and were selected for analysis. Results: The findings suggest that modifications in fat-based diets, particularly concerning the type and amount of consumed fats and fatty acids, can significantly influence plasma Lp(a) levels. Diets rich in unsaturated fats, including polyunsaturated and monounsaturated fatty acids, were associated with more favorable effects in lowering Lp(a) levels. In contrast, diets high in saturated fats were linked to elevated Lp(a) levels. However, these conclusions were not consistent across all studies considered. Conclusions: This work highlights the importance of a personalized dietary approach, considering both genetic predispositions and dietary habits. While diet alone may not drastically alter Lp(a) levels due to their strong genetic determination, a comprehensive strategy involving a healthy diet rich in unsaturated fats, regular physical activity, and effective weight management is recommended to reduce the risk of cardiovascular diseases. Further research is needed to clarify the mechanisms through which different fats affect Lp(a) and to develop targeted dietary recommendations.

19 September 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
KNKamil Nikel
Kamil Nikel
MSMichał Rafał Stojko
Michał Rafał Stojko
JSJoanna Smolarczyk
Joanna Smolarczyk
MSMagdalena Stojko
Magdalena Stojko
CGCelina Gibner
Celina Gibner
MPMagdalena Piegza
Magdalena Piegza
Introduction: Rapid advances in nutritional psychiatry highlight the central role of the gut–brain axis in the pathophysiology of mood disorders. Despite strong theoretical evidence linking poor dietary habits and dysbiosis to increased subclinical inflammation, standardized nutritional assessments and personalized dietary care are rarely implemented in routine clinical practice for patients with affective disorders. Aim of the study: The objective was to perform a prospective evaluation of the impact of personalized dietary and educational interventions on the severity of depressive, anxiety, and manic symptoms, as well as on the modification of selected anthropometric parameters and behavioral dietary patterns in female patients with bipolar disorder (BD) and recurrent depression. Materials and methods: This pilot study included a cohort of n = 25 female patients (mean age: 31.32 ± 11.23 years). The participants underwent a 12-week personalized dietary modification and nutritional education program (focused on reducing pro-inflammatory foods, establishing meal regularity, and providing targeted supplementation with omega-3 fatty acids, vitamin D3, magnesium, and sodium butyrate). Mental health status was evaluated at two time points (Point I—baseline, Point II—follow-up) using the GAD-7, HADS, MADRS, and YMRS scales. Body mass index (BMI) and dietary habit profiles were monitored concurrently. Results: At the endpoint, a significant reduction in depressive symptom severity was observed on the MADRS (from 15.52 ± 12.01 to 13.20 ± 11.66 points; p < 0.001) and HADS (from 17.00 ± 7.58 to 14.88 ± 7.82 points; p = 0.004). GAD-7 scores decreased from 8.60 ± 4.75 to 7.60 ± 4.63 points (p = 0.065),whereas YMRS scores remained stable (3.80 vs. 3.56 points). Overall, 72.0% of patients (n = 18) reported improved dietary habits, including increased rates of optimal hydration (from 36.0% to 56.0%; p = 0.031) and the adoption of targeted omega-3 supplementation (from 12.0% to 36.0%; p = 0.031). A significant correlation was demonstrated between improved diet quality and the reduction in depressive symptoms (R = −0.42; p = 0.036). Conclusions: This pilot study demonstrates that personalized dietary care is a feasible and safe adjunctive intervention for female patients with affective disorders, providing preliminary evidence of associations with reductions in depressive and anxiety symptoms alongside favorable modifications in health-related behaviors. These findings inform the design of future large-scale randomized controlled trials.